Wellness Company Wholeleaf Secures ₹1.5 Crore in Seed Funding Round

Mumbai | February 26, 2026: Wholeleaf, an all-natural pain therapeutics company, has raised ₹1.5 Crore in a seed funding round with participation from prominent investors including Aman Gupta (Co-founder & CMO, BOAT), Namita Thapar (Executive Director, Emcure Pharmaceuticals), and Kanika Tekriwal (CEO, JetSetGo), following its appearance on Shark Tank India Season 5.

Previously, the Gurgaon-based startup had raised ₹4 Crore in a funding round supported by institutional investors and notable angel investors.

The newly raised capital will be deployed to:

• Expand online presence via D2C channels.
• Strengthen offline retail presence across key metropolitan cities.
• Enhance doctor engagement and accelerate product awareness.
• Support clinical collaborations and research-led product development to create medically informed formulations.

Founded in 2020 by Shivraj Sharma, Wholeleaf develops proprietary Ayurveda-based formulations that combine cannabinoids with clinically relevant super herbs to deliver effective, long-term pain management solutions.

• Product portfolio includes topical applications, roll-ons, oils, and sprays.
• Designed to address chronic pain conditions affecting joints, muscles, and nerves.
• Served 100,000+ customers across India since inception.
• Built a strong repeat-consumer base supported by an expanding network of medical practitioners.

Currently, Wholeleaf products are available via e-commerce platforms, quick commerce channels, and leading pharmacy chains including the Apollo Pharmacy network. Expansion is underway across Mumbai, Bengaluru, Hyderabad, Kolkata, and Chennai.

Shivraj Sharma, Founder & CEO, Wholeleaf, said: “Chronic pain has remained under-addressed for millions of Indians who seek safer, natural, and long-term solutions. At Wholeleaf, we are building clinically informed, plant-based pain therapeutics that both consumers and medical professionals can trust. This fundraise allows us to expand our reach, collaborate more closely with the medical community, and invest in research-led product development. Our vision is to make natural pain relief mainstream, credible, and globally competitive.”

Strategic Roadmap

Over the next 12–18 months, Wholeleaf plans to:

• Scale operations responsibly.
• Maintain strong unit economics.
• Progress toward sustained profitability.

About Wholeleaf
Wholeleaf is one of India’s fastest-growing medically oriented natural pain therapeutics companies, focused on developing safe, effective, and long-term solutions for chronic and neuropathic pain management.

• Founded in 2020, headquartered in Gurgaon.
• Among the early licensed and compliant entrants in India’s cannabinoid-based pain therapeutics segment.
• Operates within India’s regulatory framework to develop high-quality, medically informed formulations.
• Products available across leading pharmacy chains and healthcare platforms, with a growing footprint in North India and expansion into Mumbai, Bengaluru, Hyderabad, Chennai, Kolkata, Goa, and Telangana.

🌐 Website: www.wholeleaf.in